Morpholino

MO1-ocrl

ID

ZDB-MRPHLNO-120405-1

Name

MO1-ocrl

Previous Names

ATGMO (1)

Target

ocrl (1)

Sequence

5' - AATCCCAAATGAAGGTTCCATCATG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-ocrl

Expressed Gene	Anatomy	Figures
egr2b	rhombomere 3 rhombomere 5	Fig. S7 from Ramirez et al., 2012
hoxb1a	rhombomere 4	Fig. S7 from Ramirez et al., 2012
ocrl	whole organism	Fig. 3 from Ramirez et al., 2012
pax2a	midbrain hindbrain boundary optic stalk otic vesicle	Fig. S7 from Ramirez et al., 2012

Phenotype

Phenotype resulting from MO1-ocrl

Phenotype	Fish	Figures
brain decreased size, abnormal	WT + MO1-ocrl	Fig. 6, Fig. S7 from Ramirez et al., 2012
eye decreased pigmentation, abnormal	WT + MO1-ocrl	Fig. 6 from Ramirez et al., 2012
eye decreased size, abnormal	WT + MO1-ocrl	Fig. 6 from Ramirez et al., 2012
midbrain hindbrain boundary morphology, abnormal	WT + MO1-ocrl	Fig. 6 from Ramirez et al., 2012
pinocytosis decreased efficacy, abnormal	WT + MO1-ocrl	Fig. 3. from Ates et al., 2020
pronephric duct cilium decreased amount, abnormal	AB + MO1-ocrl	Fig. 5 from Oltrabella et al., 2015
pronephric duct cilium decreased length, abnormal	AB + MO1-ocrl	Fig. 5 from Oltrabella et al., 2015
pronephric proximal convoluted tubule endocytosis decreased process quality, abnormal	AB + MO1-ocrl	Fig. 5 from Oltrabella et al., 2021
pronephros decreased functionality, abnormal	AB + MO1-ocrl	Fig. 5 from Oltrabella et al., 2021
pronephros renal absorption decreased process quality, abnormal	AB + MO1-ocrl	Fig. 1 from Oltrabella et al., 2015

Phenotype of all Fish created by or utilizing MO1-ocrl

Phenotype	Fish	Conditions	Figures
pronephros decreased functionality, abnormal	AB + MO1-ocrl	control	Fig. 5 from Oltrabella et al., 2021
pronephric duct cilium decreased amount, abnormal	AB + MO1-ocrl	standard conditions	Fig. 5 from Oltrabella et al., 2015
pronephros renal absorption decreased process quality, abnormal	AB + MO1-ocrl	standard conditions	Fig. 1 from Oltrabella et al., 2015
pronephric proximal convoluted tubule endocytosis decreased process quality, abnormal	AB + MO1-ocrl	control	Fig. 5 from Oltrabella et al., 2021
pronephric duct cilium decreased length, abnormal	AB + MO1-ocrl	standard conditions	Fig. 5 from Oltrabella et al., 2015
eye decreased pigmentation, abnormal	WT + MO1-ocrl	standard conditions	Fig. 6 from Ramirez et al., 2012
midbrain hindbrain boundary morphology, abnormal	WT + MO1-ocrl	standard conditions	Fig. 6 from Ramirez et al., 2012
eye decreased size, abnormal	WT + MO1-ocrl	standard conditions	Fig. 6 from Ramirez et al., 2012
pinocytosis decreased efficacy, abnormal	WT + MO1-ocrl	standard conditions	Fig. 3. from Ates et al., 2020
brain decreased size, abnormal	WT + MO1-ocrl	standard conditions	Fig. 6, Fig. S7 from Ramirez et al., 2012
pronephric proximal convoluted tubule endocytosis decreased process quality, abnormal	pheta1^{umc401/umc401} + MO1-ocrl (AB)	control	Fig. 5 from Oltrabella et al., 2021
pronephros decreased functionality, abnormal	pheta1^{umc401/umc401} + MO1-ocrl (AB)	control	Fig. 5 from Oltrabella et al., 2021
pronephric duct proximal region decreased functionality, abnormal	umc407Tg + MO1-ocrl + MO4-tp53	standard conditions	Fig. 2 from Naylor et al., 2022
urine protein increased amount, abnormal	umc407Tg + MO1-ocrl + MO4-tp53	standard conditions	Fig. 2 from Naylor et al., 2022

Citations